Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,065 | 4,105 | 79,599 | 0 | 0 |
| Marketable Securities | 148,235 | 90,281 | 20,345 | 0 | 0 |
| TOTAL | $154,072 | $95,663 | $100,720 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 2,552 | 1,845 | 910 | N/A | N/A |
| Other Non-Current Assets | 600 | 951 | 0 | 0 | 0 |
| TOTAL | $3,152 | $2,796 | $910 | $N/A | $N/A |
| Total Assets | $157,224 | $98,459 | $101,630 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,577 | 1,575 | 447 | 0 | 0 |
| Accrued Expenses | 1,806 | 1,495 | 460 | 0 | 0 |
| TOTAL | $3,383 | $3,070 | $907 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,291 | 710 | 253 | 0 | 0 |
| TOTAL | $1,291 | $710 | $253 | $N/A | $N/A |
| Total Liabilities | $4,674 | $3,780 | $1,160 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,407 | 20,406 | 15,706 | N/A | N/A |
| Common Shares | 2 | N/A | N/A | 0 | 0 |
| Retained earnings | -37,843 | -31,496 | -25,457 | 0 | 0 |
| Other shareholders' equity | 29 | 125,735 | 125,783 | 0 | 0 |
| TOTAL | $152,550 | $94,679 | $100,470 | $0 | $0 |
| Total Liabilities And Equity | $157,224 | $98,459 | $101,630 | $0 | $0 |